EDMOND DE ROTHSCHILD HOLDING S.A. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 189 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$8,241,000
+29.6%
154,1600.0%0.28%
+9.9%
Q3 2020$6,359,000
+8.7%
154,160
+27.8%
0.25%
+4.6%
Q2 2020$5,848,000
+14.7%
120,6600.0%0.24%
-9.7%
Q1 2020$5,098,000
+65.3%
120,660
+67.4%
0.27%
+118.9%
Q4 2019$3,084,000
-19.2%
72,100
-32.0%
0.12%
-20.3%
Q3 2019$3,815,000
-52.5%
106,000
-64.7%
0.15%
-49.3%
Q2 2019$8,027,000
-21.7%
300,300
-21.4%
0.30%
-14.9%
Q1 2019$10,257,000
+54.0%
382,000
-7.3%
0.36%
+51.7%
Q4 2018$6,662,000
-21.7%
412,000
+0.5%
0.23%
-3.3%
Q3 2018$8,512,000
+50.9%
410,000
+11.0%
0.24%
+50.3%
Q2 2018$5,641,000
-26.2%
369,452
+8.7%
0.16%
-27.5%
Q1 2018$7,640,000
-25.4%
340,0000.0%0.22%
-24.5%
Q4 2017$10,237,000
-41.6%
340,000
-26.9%
0.29%
-41.1%
Q3 2017$17,517,000
+32.2%
465,000
-2.1%
0.50%
+33.8%
Q2 2017$13,248,000
+21.8%
475,000
+50.1%
0.37%
+29.5%
Q1 2017$10,877,000
+277.1%
316,380
+216.4%
0.29%
+260.0%
Q4 2016$2,884,000100,0000.08%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders